Avacta is a clinical stage oncology drug company and developer of powerful diagnostics based on its innovative, proprietary Affimer® and pre|CISION™ platforms.
Registrars: | Capita Registrars |
Non-Executive Director: | Mark Goldberg, Darlene Deptula-Hicks , Trevor Nichols, Paul Fry |
Non-Executive Chairman: | Shaun Chilton |
Address: | Unit 20, Ash Way, Thorp Arch Estate, Wetherby, United Kingdom |
Phone: | +44 (0)1904 21 7070 |
Fax: | +44 (0)84 4414 0453 |
Website: | http://www.avacta.com |
Email: |
ISIN: | GB00BYYW9G87 |
Sector: | Pharma and Biotech, Pharma and Biotech |
Main Indices: | FTSE AIM All-Share |